ArticleNucleic acids research2015

Targeting chromatin binding regulation of constitutively active AR variants to overcome prostate cancer resistance to endocrine-based therapies.

Siu Chiu Chan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.